Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Thorac Oncol. 2020 Mar 13;15(7):1210–1222. doi: 10.1016/j.jtho.2020.03.003

Figure 4.

Figure 4.

(A) Progression-free survival (IRC adjudicated) and (B) overall survival in PD-L1-evaluable patients who received bintrafusp alfa 1200 mg. IRC, independent review committee; NR, not reached; PD-L1, programmed death-ligand 1; CI, confidence interval.